1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with stilbenes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braeuning, A; Dusek, J; Hirsova, P; Holas, O; Horvatova, A; Kucera, O; Linhartova, L; Micuda, S; Pavek, P; Skoda, J; Smutny, T | 1 |
1 other study(ies) available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and stilbenes
| Article | Year |
|---|---|
Stilbene compound trans-3,4,5,4ยด-tetramethoxystilbene, a potential anticancer drug, regulates constitutive androstane receptor (Car) target genes, but does not possess proliferative activity in mouse liver.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cell Proliferation; Constitutive Androstane Receptor; Cytochrome P450 Family 2; Gene Expression Regulation, Enzymologic; Gluconeogenesis; Hep G2 Cells; Hepatocytes; Humans; Lipogenesis; Liver; Liver Neoplasms; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Pyridines; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Steroid Hydroxylases; Stilbenes | 2019 |